Literature DB >> 1663529

Identification of a dopamine- and 3'5'-cyclic adenosine monophosphate-regulated phosphoprotein of 32 kD (DARPP-32) in parathyroid hormone-producing cells of the human parathyroid gland.

B Meister1, J Askergren, G Tunevall, H C Hemmings, P Greengard.   

Abstract

The cellular localization of DARPP-32, a dopamine- and cyclic AMP-regulated phosphoprotein of 32 kD, enriched in dopamine-innervated brain regions, was investigated in the human parathyroid gland using indirect immunofluorescence histochemistry. Monoclonal antibodies were used to demonstrate DARPP-32-like immunoreactivity (LI) in chief cells of the normal human parathyroid gland and in cells of human parathyroid adenoma. Direct double-labelling revealed coexistence of DARPP-32-LI with parathyroid hormone (PTH)-LI. It has previously been demonstrated that dopamine D1-receptors are present in the parathyroid gland and that dopamine and D1-agonists stimulate the release of PTH. The present results suggest that DARPP-32 may play a role in the cellular mechanisms leading to dopamine-induced PTH secretion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663529     DOI: 10.1007/BF03347888

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  39 in total

1.  Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.

Authors:  B Meister; J Fryckstedt; M Schalling; R Cortés; T Hökfelt; A Aperia; H C Hemmings; A C Nairn; M Ehrlich; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.

Authors:  H C Hemmings; P Greengard; H Y Tung; P Cohen
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

3.  Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine.

Authors:  J L Platt; A F Michael
Journal:  J Histochem Cytochem       Date:  1983-06       Impact factor: 2.479

4.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus.

Authors:  H C Hemmings; A C Nairn; D W Aswad; P Greengard
Journal:  J Neurosci       Date:  1984-01       Impact factor: 6.167

5.  A simple method of reducing the fading of immunofluorescence during microscopy.

Authors:  G D Johnson; G M Nogueira Araujo
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

6.  Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices.

Authors:  S Halpain; J A Girault; P Greengard
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

7.  Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II.

Authors:  J A Girault; H C Hemmings; K R Williams; A C Nairn; P Greengard
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

8.  Dopamine D1 receptors in human parathyroid gland: in vitro and in vivo studies.

Authors:  A J Cross; I N Ferrier; C A Bloxham
Journal:  Life Sci       Date:  1983-08-22       Impact factor: 5.037

9.  Characterization of the dopamine-responsive adenylate cyclase of bovine parathyroid cells and its relationship to parathyroid hormone secretion.

Authors:  M F Attie; E M Brown; D G Gardner; A M Spiegel; G D Aurbach
Journal:  Endocrinology       Date:  1980-12       Impact factor: 4.736

10.  Effect of dopamine on parathyroid hormone release during surgery.

Authors:  K Mikawa; M Kusunoki; Y Fujii; H Obara; S Iwai
Journal:  Thorac Cardiovasc Surg       Date:  1989-08       Impact factor: 1.827

View more
  2 in total

1.  Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner.

Authors:  Christian Hansen; Jillian Howlin; Anders Tengholm; Oleg Dyachok; Wolfgang F Vogel; Angus C Nairn; Paul Greengard; Tommy Andersson
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

2.  Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases.

Authors:  Sven Ivar Walaas; Hugh Caroll Hemmings; Paul Greengard; Angus Clark Nairn
Journal:  Front Neuroanat       Date:  2011-08-26       Impact factor: 3.856

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.